An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

A Virtual Reality System for Delivery of Military-Specific Vestibular Rehabilitation After Mild Traumatic Brain Injury: The Praxis Study Protocol

Panic Disorders in Patients with Vestibular Dysfunction: A Systematic Review and Meta-Analysis

Ectoderm Barcoding Reveals Neural and Cochlear Compartmentalization

Recent Posts

A Virtual Reality System for Delivery of Military-Specific Vestibular Rehabilitation After Mild Traumatic Brain Injury: The Praxis Study Protocol

In an article by Alroumi et al. (2025), treatment of mild traumatic brain injury (mTBI) through the use of virtual reality (VR) system was investigated….

Read More

From Capitol Hill to Your Clinic: SPAN July Meeting on Medicaid Cuts

The State Policy Advocacy Network (SPAN) will convene again on July 29 for a critical meeting about Medicaid funding. SPAN brings together nationwide audiologists and…

Read More
The White House from the sky

EHDI Program at Risk

On April 1, President Trump’s administration eliminated the entire branch of the Early Hearing Detection and Intervention (EHDI) program that works with states to analyze…

Read More